Article
Comparison of Next-Generation Sequencing and Ventana Immunohistochemistry in Detecting ALK…
OncoTargets and Therapy · 2020 · Zeng L, Li Y, Xu Q, Jiang W, Lizaso A, Mao X, Zhang Y, Yang N, Wang Z
Key facts
| Title | Comparison of Next-Generation Sequencing and Ventana Immunohistochemistry in Detecting ALK Rearrangements and Predicting the Efficacy of First-Line Crizotinib in Patients with Advanced Non-Small Cell Lung Cancer |
|---|---|
| First author | Zeng L, Li Y, Xu Q, Jiang W, Lizaso A, Mao X, Zhang Y, Yang N, Wang Z |
| Journal | OncoTargets and Therapy |
| Published | Jul 22, 2020 |
| DOI | 10.2147/OTT.S265974 |
| Devices mentioned | 215006, DEN040010, DEN130010, K010288, K091960, K100015, K131508, K953591, K954214, K962873, P110012, P150041 |
| Product codes mentioned | KIR, OVQ, OYU, OXP, MVU, NTH, OWE, OWK, PDO, PFG, PNK, PPM |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1